The integrated genomic and immune landscapes of lethal metastatic breast cancer (MBC).

1009Background: The heterogeneous fates of MBC preclude our understanding of both resistance to therapy and escape from cancer immunoediting. Here, we performed a comprehensive molecular analysis o...